Wells Fargo downgraded Ironwood Pharma from Overweight to Equal Weight
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/15/2025 | Overweight → Equal Weight | Wells Fargo | |
| 4/15/2025 | Buy → Hold | Jefferies | |
| 4/14/2025 | Mkt Outperform → Mkt Perform | Citizens JMP | |
| 9/9/2024 | $5.00 | Market Perform | Leerink Partners |
| 8/8/2024 | $12.00 → $4.00 | Overweight → Equal Weight | CapitalOne |
| 1/17/2024 | $21.00 | Buy | Craig Hallum |
| 12/14/2023 | $20.00 | Overweight | Wells Fargo |
| 11/9/2023 | $21.00 | Buy | Jefferies |
Wells Fargo downgraded Ironwood Pharma from Overweight to Equal Weight
Jefferies downgraded Ironwood Pharma from Buy to Hold
Citizens JMP downgraded Ironwood Pharma from Mkt Outperform to Mkt Perform
4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)